Saturday, August 23, 2025

Curaleaf Partially Closes Acquisition of Acres Cannabis

Curaleaf Holdings (CSE: CURA) has partially completed its acquisition of Nevada-based Acres Cannabis. The acquisition, which was originally announced in March of this year, includes a 269,000 square foot cultivation facility, as well as 3,200 square foot processing lab.

The assets that Curaleaf has closed on are all located in Amargosa Valley, and referred to as the entities cultivation assets. What’s key, is that the entire acquisition of Acres has not been completed, which is not explicitly clear in the headline of the firms news release. Two dispensaries, one in Ely and one in Las Vegas, and a processing facility located in Las Vegas have yet to close as Curaleaf works with regulators.

The dispensary located in Las Vegas is regarded as being the flagship of Acres Cannabis.

The acquisition of the Nevada assets was originally announced March 18, when they indicated that they would be purchasing the Nevada based operator for US$70 million. Included in the purchase price is $25 million in cash, and $45 million to be paid via Curaleaf stock. Additional undisclosed performance targets are available for the assets as well, which may increase the final purchase price.

Acres cultivation is the largest cultivator in the state of Nevada, growing 227,000 square feet of product outdoors, while 42,000 square feet consist of greenhouse space. An additional 133,000 square feet of production capacity is currently under construction. When complete, the facility is expected to produce in excess of 100,000 pounds of cannabis, or approximately 45,300 kilograms.

The final transfer of Acres Cannabis assets is expected to occur before the end of the year as per the company’s news release.

Curaleaf Holdings closed yesterday’s session at $6.83 on the Canadian Securities Exchange.


Information for this briefing was found via Curaleaf Holdings. The author has no securities or affiliations related to the discussed organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Curaleaf Consensus Target Remains Flat After Record Quarter

On August 9, Curaleaf Holdings (CSE: CURA) reported record second quarter financial results. The company...

Tuesday, August 17, 2021, 11:43:00 AM

Curaleaf: Haywood Predicts Slower Growth Into 2022

Curaleaf Holdings (CSE: CURA) announced that they would be reporting their third quarter financial results...

Sunday, October 31, 2021, 02:40:00 PM

Canaccord Lowers Curaleaf’s Price Target After Soft Q3 Results

On November 8th, Curaleaf Holdings (CSE: CURA) reported its third-quarter financial results. The firm reported...

Saturday, November 13, 2021, 10:15:00 AM

Curaleaf Holdings To Raise C$275.6 Million Via Overnight Marketed Offering

Curaleaf Holdings (CSE: CURA) this morning released the pricing of its previously announced overnight marketed...

Thursday, January 7, 2021, 10:14:18 AM

Curaleaf Holdings Reports Negative Revenue Growth In Q1, Replaces CEO

Growth appears to have gone negative within the US cannabis space. Following Green Thumb Industries...

Tuesday, May 10, 2022, 08:23:47 AM